Education

University of Puget Sound, Tacoma, WA, B.S., 1978-1982, Biology
Stanford University, Stanford, CA, Ph.D., 1982-1987, Cancer Biology
Stanford University, Stanford, CA, post-doc, 1987-1989, Tumor immunology and immunotherapy

Honors & Awards

  • 1982-1986
    NIH - National Research Service Award, Graduate Fellowship
  • 1987-1988
    Stanford University Dean's Postdoctoral Fellowship Award
  • 1988-1989
    NIH - National Research Service Award, Postdoctoral Fellowship

Selected Publications

  1. Glencer AC, Wong JM, Hylton NM, Krings G, McCune E, Rothschild HT, Loveday TA, Alvarado MD, Esserman LJ, Campbell MJ Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection.  View on PubMed
  2. Mori H, Bolen J, Schuetter L, Massion P, Hoyt CC, VandenBerg S, Esserman L, Borowsky AD, Campbell MJ Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence.  View on PubMed
  3. Sayaman RW, Saad M, Thorsson V, Hu D, Hendrickx W, Roelands J, Porta-Pardo E, Mokrab Y, Farshidfar F, Kirchhoff T, Sweis RF, Bathe OF, Heimann C, Campbell MJ, Stretch C, Huntsman S, Graff RE, Syed N, Radvanyi L, Shelley S, Wolf D, Marincola FM, Ceccarelli M, Galon J, Ziv E, Bedognetti D Germline genetic contribution to the immune landscape of cancer.  View on PubMed
  4. Campbell MJ, Baehner F, O'Meara T, Ojukwu E, Han B, Mukhtar R, Tandon V, Endicott M, Zhu Z, Wong J, Krings G, Au A, Gray JW, Esserman L Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.  View on PubMed
  5. Campbell MJ, Wolf D, Mukhtar RA, Tandon V, Yau C, Au A, Baehner F, van't Veer L, Berry D, Esserman LJ The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context.  View on PubMed
  6. Adisa CA, Eleweke N, Alfred AA, Campbell MJ, Sharma R, Nseyo O, Tandon V, Mukhtar R, Greninger A, Risi JD, Esserman LJ Biology of breast cancer in Nigerian women: a pilot study.  View on PubMed
  7. Mukhtar RA, Moore AP, Tandon VJ, Nseyo O, Twomey P, Adisa CA, Eleweke N, Au A, Baehner FL, Moore DH, McGrath MS, Olopade OI, Gray JW, Campbell MJ, Esserman LJ Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer.  View on PubMed
  8. Mukhtar RA, Moore AP, Nseyo O, Baehner FL, Au A, Moore DH, Twomey P, Campbell MJ, Esserman LJ Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity.  View on PubMed
  9. Mukhtar RA, Nseyo O, Campbell MJ, Esserman LJ Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics.  View on PubMed
  10. Campbell MJ, Tonlaar NY, Garwood ER, Huo D, Moore DH, Khramtsov AI, Au A, Baehner F, Chen Y, Malaka DO, Lin A, Adeyanju OO, Li S, Gong C, McGrath M, Olopade OI, Esserman LJ Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome.  View on PubMed
  11. Zavodovskaya M, Campbell MJ, Maddux BA, Shiry L, Allan G, Hodges L, Kushner P, Kerner JA, Youngren JF, Goldfine ID Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.  View on PubMed
  12. Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC Breast cancer growth prevention by statins.  View on PubMed
  13. Jabrane-Ferrat N, Campbell MJ, Esserman LJ, Peterlin BM Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice.  View on PubMed
  14. Gable KL, Maddux BA, Penaranda C, Zavodovskaya M, Campbell MJ, Lobo M, Robinson L, Schow S, Kerner JA, Goldfine ID, Youngren JF Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth.  View on PubMed
  15. Shoemaker M, Hamilton B, Dairkee SH, Cohen I, Campbell MJ In vitro anticancer activity of twelve Chinese medicinal herbs.  View on PubMed
  16. Campbell MJ, Scott J, Maecker HT, Park JW, Esserman LJ Immune dysfunction and micrometastases in women with breast cancer.  View on PubMed
  17. Campbell MJ, Hamilton B, Shoemaker M, Tagliaferri M, Cohen I, Tripathy D Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro.  View on PubMed
  18. Campbell MJ, Wollish WS, Lobo M, Esserman LJ Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.  View on PubMed
  19. Mukherjee S, Louie SG, Campbell M, Esserman L, Shyamala G Ductal growth is impeded in mammary glands of C-neu transgenic mice.  View on PubMed
  20. Borden EC, Esserman L, Linder DJ, Campbell MJ, Fulton AM Biological therapies for breast carcinoma: concepts for improvement in survival.  View on PubMed

Go to UCSF Profiles, powered by CTSI